| Autor: |
Sadeq Tabatabai, Nooshin Bazargani, Kamaleldin Al-Tahmody, Jasem Mohammed Alhashmi |
| Jazyk: |
angličtina |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Dubai Medical Journal, Pp 330-333 (2021) |
| Druh dokumentu: |
article |
| ISSN: |
2571-726X |
| DOI: |
10.1159/000520461 |
| Popis: |
Soon after it was discovered in Wuhan, China, in December 2019, coronavirus disease 2019 (COVID-19) blow-out very fast and became a pandemic. The usual presentation is respiratory tract infection, but cardiovascular system involvement is sometimes fatal and also a serious personal and health care burden. We report a case of a 57-year-old man who was admitted with anterior wall acute myocardial infarction secondary to early coronary stent thrombosis and associated with COVID-19 infection. He was managed with primary coronary angioplasty and discharged home. Procoagulant and hypercoagulability status associated with severe acute respiratory syndrome coronavirus 2 infection is the most likely culprit. Choosing aggressive antithrombotic agents after coronary angioplasty to prevent stent thrombosis during the COVID-19 pandemic may be the answer but could be challenging. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
